Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis
Status:
Completed
Trial end date:
2018-05-31
Target enrollment:
Participant gender:
Summary
This is a Phase 3 study to evaluate the safety and efficacy of a vancomycin hydrochloride
ophthalmic ointment dosed 4 times daily for 7 days compared to placebo (vehicle) in patients
with moderate to severed Gram-positive bacterial conjunctivitis.